Aligos Therapeutics Inc (ALGS)
NASDAQ
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -25.866 | -41.112 | -52.714 | -51.264 | -50.278 | -58.802 |
Return on Equity (%) | 202.691 | 132.921 | -139.922 | -63.41 | -66.553 | -89.477 |
Return on Invested Capital (%) | -31.543 | -55.866 | -59.945 | -66.081 | -71.693 | -91.117 |
Operating Margin (%) | N/A | N/A | N/A | -2940.789 | -689.868 | -559.495 |
Net Profit Margin (%) | N/A | N/A | N/A | -2944.07 | -690.631 | -564.615 |
Book Value Per Share | 28.571 | 29.834 | 6.011 | 4.327 | 2.421 | 1.229 |
Earnings Per Share | -4.588 | -13.305 | -2.965 | -3.006 | -2.238 | -1.17 |
Cash Per Share | 7.914 | 17.71 | 6.02 | 4.376 | 1.895 | 1.811 |
Working Capital Per Share | 27.949 | 27.09 | 6.003 | 3.876 | 2.339 | 1.564 |
Operating Profit Per Share | N/A | N/A | N/A | 0.102 | 0.324 | 0.207 |
EBIT Per Share | -4.588 | -13.284 | -2.961 | -3.003 | -2.235 | -1.16 |
EBITDA Per Share | -4.588 | -13.284 | -2.961 | -3.003 | -2.235 | -1.16 |
Free Cash Flow Per Share | -3.796 | -12.952 | -2.983 | -3.056 | -2.301 | -1.191 |
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 3,04M | 3,93M | 36,61M | 42,69M | 42,92M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | 42,92M | N/A | 43,5M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -841.572 | N/A | N/A | N/A | -3533.367 | N/A | N/A |
Net Profit Margin (%) | N/A | -843.004 | N/A | N/A | N/A | -3535.801 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 142,87M |
Ratio cours/bénéfice | -1,63 |
Ratio prix/ventes | 9,2 |
Ratio prix/liquidités | 1,05 |
Ratio prix/valeur comptable | 1,55 |
Rendement de dividende | - |
Actions en circulation | 3,59M |
Volume moyen (1 semaine) | 472,82k |
Volume moyen (1 mois) | 464,43k |
Variation sur 52 semaines | 137,73% |
Plus haut sur 52 semaines | 44,39 |
Plus bas sur 52 semaines | 6,76 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales